Records containing: Hepatitis B
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-06Pilot Testing and Evaluation of a Nurse-led Decision Counseling Program to Improve Decision-making and Uptake of Hepatocellular Carcinoma Screening Among Patients With Hepatitis B Virus Infection: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-04-06Follow-up of HBsAg Inactive Carriers Study
-
CLINICAL_TRIALS study record update · 2022-04-06Persistence of Anti-Hep B Antibodies at 9 to 10 Years of Age in Subjects Having Received Hep B Vaccine at Birth and a DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine at 2, 4 and 6 Months of Age, and Evaluation of Their Immune Memory Following a Challenge Re-vaccination With a Stand Alone Hep B Vaccine
-
CLINICAL_TRIALS study record update · 2022-04-05Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-HB-PRP-T Combined Vaccine Given as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and in HIV-Exposed Uninfected Infants in Republic of South Africa
-
CLINICAL_TRIALS study record update · 2022-04-05Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine Given as a Three-Dose Primary Series at 2, 3, and 4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-31Study on the Optimal Strategy for Acute-on-chronic Liver Failure Combined With Traditional Chinese and Modern Medicine: a Multi-center, Randomized and Controlled Study
-
CLINICAL_TRIALS study record update · 2022-03-23Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal
-
CLINICAL_TRIALS study record update · 2022-03-11Immunologic Efficacy of Heplisav B Vaccine in Patients Undergoing Treatment With Immunosuppressive Medications
-
CLINICAL_TRIALS study record update · 2022-02-07Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2022-01-31Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV
-
CLINICAL_TRIALS study record update · 2022-01-26Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
-
CLINICAL_TRIALS study record update · 2022-01-10Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
-
CLINICAL_TRIALS study record update · 2021-12-03Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays
-
CLINICAL_TRIALS study record update · 2021-12-01A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in Healthy Volunteer Subjects
-
CLINICAL_TRIALS study record update · 2021-11-03A Prospective Study of Hepatitis B Virus (HBV) Immunity and Hepatitis B Vaccination in Patients With Non Alcoholic Fatty Liver Disease (NAFLD) in Canada
-
CLINICAL_TRIALS study record update · 2021-11-02Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C in Hainan Province Danzhou City
-
CLINICAL_TRIALS study record update · 2021-11-01Multicenter, Pilot Study of Telbivudine (LdT) Anti-HBV Treatment Prior to the Initiation of Highly Active Antiretroviral Therapy Containing Lamivudine in Subjects Coinfected With HBV and HIV
-
CLINICAL_TRIALS study record update · 2021-11-01Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)
-
CLINICAL_TRIALS study record update · 2021-11-01A Phase II Study of Adefovir Dipivoxil, Pegylated Interferon Alfa-2A, and Ribavirin Treatment in HBV and HCV Infected Subjects With HIV Disease
-
CLINICAL_TRIALS study record update · 2021-11-01A Randomized, Phase II, Controlled Trial Comparing the Efficacy of Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B Virus in Subjects Who Are Co-Infected With HIV
-
CLINICAL_TRIALS study record update · 2021-10-26Prevention of HCC Using Mobile Phone Applications: A Disease Management Project Based on CR-HepB Platform
-
CLINICAL_TRIALS study record update · 2021-10-21Re-compensation and Its Clinical Characteristics in Treatment-naïve HBV Decompensated Cirrhosis on Antiviral Therapy
-
CLINICAL_TRIALS study record update · 2021-09-05A Hepatitis B Vaccine Challenge Study to Demonstrate the Durability of Protection Against Hepatitis B Virus Infection in Healthy Children Vaccinated Approximately 9 Years Previously With a 2- or 3-Dose Infant Series and Toddler Dose of Vaxelis®
-
CLINICAL_TRIALS study record update · 2021-08-26A Multicenter, Open-label, Phase II Clinical Study to Evaluate the Safety and Efficacy of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
-
CLINICAL_TRIALS study record update · 2021-08-25A Phase II Open-Label Study of Ledipasvir/Sofosbuvir for 12 Weeks in Subjects With Hepatitis B Virus Infection